Results 171 to 180 of about 88,551 (311)

Analysis of Antibiotic Exposure and Development of Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation.

open access: yesJAMA Netw Open, 2023
Rashidi A   +7 more
europepmc   +1 more source

Early Endothelial Activation in a Mouse Model of Graft vs Host Disease Following Chemotherapy. [PDF]

open access: yesFront Immunol, 2021
Pereira M   +13 more
europepmc   +1 more source

HLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment [PDF]

open access: yes, 2018
DiPersio, John F.   +6 more
core   +1 more source

Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity. [PDF]

open access: yesTransplant Cell Ther
Louloudis IE   +33 more
europepmc   +1 more source

Mechanisms of spinal glial activation in chemotherapy‐induced peripheral neuropathy: Focus on microglia and astrocytes

open access: yesIbrain, EarlyView.
Chemotherapy‐induced peripheral neuropathy (CIPN) remains a major clinical challenge, with central sensitization considered an important pathological mechanism in its occurrence and persistence. This review focuses on spinal astrocytes and microglia, systematically summarizing the pathological mechanisms of spinal glial cells involved in CIPN caused by
Long Gu, Song Cao, Yonghuai Feng
wiley   +1 more source

Transfusion-Associated Graft-vs-Host Disease [PDF]

open access: yesAmerican Journal of Clinical Pathology, 2000
Timothy E. Gorman   +7 more
openaire   +1 more source

Molecular imprinting for neurology: Materials, applications, and limitations

open access: yesIbrain, EarlyView.
Molecularly imprinted materials: diagnostic, therapeutic and research applications in neurology. Molecularly imprinted materials offer high specificity and affinity for target molecules in neurological applications. This review highlights their synthesis, characterisation, and use in diagnostics, research and therapeutics.
Xiaohan Ma   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy